Xu S - Search Results

1

Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer.

Xu S, Zhan M, Jiang C, He M, Yang L, Shen H, Huang S, Huang X, Lin R, Shi Y, Liu Q, Chen W, Mohan M, Wang J. Xu S, et al. Nat Commun. 2019 Dec 2;10(1):5492. doi: 10.1038/s41467-019-13420-x. Nat Commun. 2019. PMID: 31792210 Free PMC article. Clinical Trial.

2

NOX1 mediates chemoresistance via HIF1α/MDR1 pathway in gallbladder cancer.

Zhan M, Wang H, Chen T, Chen W, Yang L, He M, Xu S, Wang J. Zhan M, et al. Among authors: xu s. Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):79-85. doi: 10.1016/j.bbrc.2015.10.161. Epub 2015 Nov 9. Biochem Biophys Res Commun. 2015. PMID: 26545779

3

miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1.

Zhan M, Zhao X, Wang H, Chen W, Xu S, Wang W, Shen H, Huang S, Wang J. Zhan M, et al. Among authors: xu s. Tumour Biol. 2016 Aug;37(8):10553-62. doi: 10.1007/s13277-016-4957-6. Epub 2016 Feb 8. Tumour Biol. 2016. PMID: 26852750

4

miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer.

Yang D, Zhan M, Chen T, Chen W, Zhang Y, Xu S, Yan J, Huang Q, Wang J. Yang D, et al. Among authors: xu s. Sci Rep. 2017 Mar 3;7:43109. doi: 10.1038/srep43109. Sci Rep. 2017. PMID: 28256505 Free PMC article.

5

miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.

Wang H, Zhan M, Xu SW, Chen W, Long MM, Shi YH, Liu Q, Mohan M, Wang J. Wang H, et al. Cell Death Dis. 2017 May 11;8(5):e2770. doi: 10.1038/cddis.2017.178. Cell Death Dis. 2017. PMID: 28492560 Free PMC article.

6

MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.

He M, Zhan M, Chen W, Xu S, Long M, Shen H, Shi Y, Liu Q, Mohan M, Wang J. He M, et al. Among authors: xu s. Cell Physiol Biochem. 2017;42(5):2078-2092. doi: 10.1159/000479903. Epub 2017 Aug 11. Cell Physiol Biochem. 2017. PMID: 28803245 Free article.

7

miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis.

Yang RM, Zhan M, Xu SW, Long MM, Yang LH, Chen W, Huang S, Liu Q, Zhou J, Zhu J, Wang J. Yang RM, et al. Among authors: xu sw. Cell Death Dis. 2017 Oct 19;8(10):e3129. doi: 10.1038/cddis.2017.530. Cell Death Dis. 2017. PMID: 29048402 Free PMC article.

8

miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.

Long M, Zhan M, Xu S, Yang R, Chen W, Zhang S, Shi Y, He Q, Mohan M, Liu Q, Wang J. Long M, et al. Among authors: xu s. Mol Cancer. 2017 Oct 27;16(1):167. doi: 10.1186/s12943-017-0723-7. Mol Cancer. 2017. PMID: 29078789 Free PMC article.

9

Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks.

Xu S, Zhan M, Wang J. Xu S, et al. Cell Death Discov. 2017 Nov 27;3:17069. doi: 10.1038/cddiscovery.2017.69. eCollection 2017. Cell Death Discov. 2017. PMID: 29188076 Free PMC article. Review.

10

PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2.

Shen H, Zhan M, Zhang Y, Huang S, Xu S, Huang X, He M, Yao Y, Man M, Wang J. Shen H, et al. Among authors: xu s. Cell Death Dis. 2018 Jan 22;9(2):71. doi: 10.1038/s41419-017-0107-3. Cell Death Dis. 2018. PMID: 29358655 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,326 results

Search Page

Filters